छोड़कर सामग्री पर जाएँ

Stelis Biopharma receives EIR from the US FDA for Drug-Device Combination Products

The US FDA’s EIR is received for the drug-device combination to be commercialised from the Stelis Pharma#39;s flagship facility in Bengaluru, India

Read More

​ The US FDA’s EIR is received for the drug-device combination to be commercialised from the Stelis Pharma#39;s flagship facility in Bengaluru, India The US FDA’s EIR is received for the drug-device combination to be commercialised from the Stelis Pharma#39;s flagship facility in Bengaluru, India  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी